Category: News and Views

JDNPPA Expert Reaction: U.S. FDA Approves Roflumilast Cream 0.05% for AD in Kids Aged 2 to 5 Featuring Dr. Lawrence Eichenfield

Lawrence F. Eichenfield, MD, discusses the recent FDA nod for roflumilast cream 0.05% in kids aged 2 to 5 with AD.